Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.14
+0.23 (2.91%)
At close: Jul 30, 2026, 4:00 PM EDT
8.11
-0.03 (-0.37%)
After-hours: Jul 30, 2026, 7:52 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $504.55 million as of July 30, 2026. Its market cap has increased by 189.37% in one year.
Market Cap
504.55M
Enterprise Value
347.29M
1-Year Change
189.37%
Ranking
Category
Stock Price
$8.14
ChartMarket Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $504.55M, an increase of 453.87%. That is a compound annual growth rate of 34.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 504.55M | 23.60% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 526.64M |
| 4D Molecular Therapeutics | 521.72M |
| Zura Bio | 516.79M |
| Verastem | 513.62M |
| Artiva Biotherapeutics | 509.69M |
| Ginkgo Bioworks Holdings | 508.88M |
| Eikon Therapeutics | 508.63M |
| Rezolute | 504.05M |